H. A. TUFAN Et Al. , "Tufan HA, Gencer B, Çömez AT, Özdek Ş. Intravitreal Bevacizumab Treatment for Chronic Central Serous Chorioretinopathy Presumably Associated with Trigger Point Steroid Injection. Retina-Vitreus," Retina-Vitreus , vol.21, no.3, pp.219-222, 2013
TUFAN, H. A. Et Al. 2013. Tufan HA, Gencer B, Çömez AT, Özdek Ş. Intravitreal Bevacizumab Treatment for Chronic Central Serous Chorioretinopathy Presumably Associated with Trigger Point Steroid Injection. Retina-Vitreus. Retina-Vitreus , vol.21, no.3 , 219-222.
TUFAN, H. A., GENCER, B., TAŞKIRAN ÇÖMEZ, A., & ÖZDEK, Ş., (2013). Tufan HA, Gencer B, Çömez AT, Özdek Ş. Intravitreal Bevacizumab Treatment for Chronic Central Serous Chorioretinopathy Presumably Associated with Trigger Point Steroid Injection. Retina-Vitreus. Retina-Vitreus , vol.21, no.3, 219-222.
TUFAN, HASAN Et Al. "Tufan HA, Gencer B, Çömez AT, Özdek Ş. Intravitreal Bevacizumab Treatment for Chronic Central Serous Chorioretinopathy Presumably Associated with Trigger Point Steroid Injection. Retina-Vitreus," Retina-Vitreus , vol.21, no.3, 219-222, 2013
TUFAN, HASAN A. Et Al. "Tufan HA, Gencer B, Çömez AT, Özdek Ş. Intravitreal Bevacizumab Treatment for Chronic Central Serous Chorioretinopathy Presumably Associated with Trigger Point Steroid Injection. Retina-Vitreus." Retina-Vitreus , vol.21, no.3, pp.219-222, 2013
TUFAN, H. A. Et Al. (2013) . "Tufan HA, Gencer B, Çömez AT, Özdek Ş. Intravitreal Bevacizumab Treatment for Chronic Central Serous Chorioretinopathy Presumably Associated with Trigger Point Steroid Injection. Retina-Vitreus." Retina-Vitreus , vol.21, no.3, pp.219-222.
@article{article, author={HASAN ALİ TUFAN Et Al. }, title={Tufan HA, Gencer B, Çömez AT, Özdek Ş. Intravitreal Bevacizumab Treatment for Chronic Central Serous Chorioretinopathy Presumably Associated with Trigger Point Steroid Injection. Retina-Vitreus}, journal={Retina-Vitreus}, year=2013, pages={219-222} }